TABLE 2.

Survival outcome of OS.

Study	CAR T	Median Overall Survival, months	Median Follow up, months
Jacobson et al. (2020)	axi-cel	23.8 (13.5–NR)	27.1
Abramson et al. (2020)	liso-cel	27.03 (16.2–45.6)	29.3
Schuster et al. (2019)	tisa-cel	12.0 (7.0–NR)	14.0
Zhou et al. (2020)	lab	23.8	13.7
Iacoboni et al. (2021)	tisa-cel	10.7 (7.4–NR)	14.1

CAR T: chimeric antigen receptor T cells; NR: not reached